Studies have shown that 5-ALA increases apoptotic cell death in resistant prostate cancer cells [31] and enhancement of intracellular PP-IX induces p53-dependent apoptosis in lymphocytic leukemia cells [32]. The gene discussed is TP53; the disease is prostate carcinoma.